Abstract
Brain death can be determined by clinical examination and the diagnosis confirmed by a variety of laboratory studies. While the most widely used has been the EEG, newer tests are playing an increasingly important role in confirming brain death. The authors discuss the role of one of these tests, the radioisotope brain scan (RIBS), which measures cerebral blood flow. Advantages and limitations of this procedure are outlined and compared with those of the EEG. (KIE abstract)
